Evolve Biologics, Therapure Biopharma’s Biologics Division, Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering Facebook Twitter Pinterest LinkedInMarch 28, 2018 – Business Wire Facebook Twitter Pinterest LinkedIn